SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Stemline Therapeutics, Inc. Announces Two Presentations of Direct Injection Synthetic Peptide Vaccine for Brain Cancer, Now Being Developed as SL-701, at the Annual Meeting of the American Association for Cancer Research (AACR)